Finance
Halozyme Therapeutics Inc. (HALO): Major Improvements, Need To Be Considered
Halozyme Therapeutics Inc. (NASDAQ:HALO) concluded the trading at $38.61 on Friday, April 12 with a fall of -1.81% from its closing price on previous day.
Halozyme Therapeutics Inc. (NASDAQ:HALO) concluded the trading at $38.61 on Friday, April 12 with a fall of -1.81% from its closing price on previous day.
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.